Showing 4521-4540 of 8875 for: Cochrane Systematic Reviews Back
- Ivermectin and permethrin for treating scabies
Cochrane Systematic Reviews, 2-Apr-2018
Scabies is an intensely itchy parasitic infection of the skin. It occurs worldwide, but is particularly problematic in areas of poor sanitation, overcrowding, and social disruption. In recent years, permethrin and ivermectin have become the most relevant
- Ivermectin for onchocercal eye disease (river blindness)
Cochrane Systematic Reviews, 15-Aug-2012
It is believed that ivermectin (a microfilaricide) could prevent blindness due to onchocerciasis. However, when given to everyone in communities where onchocerciasis is common, the effects of ivermectin on lesions affecting the eye are uncertain and data
- Ivermectin for preventing and treating COVID‐19
Cochrane Systematic Reviews, 21-Jun-2022
Ivermectin, an antiparasitic agent, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication i
- Ivermectin treatment in humans for reducing malaria transmission
Cochrane Systematic Reviews, 29-Jun-2021
Malaria is transmitted through the bite of Plasmodium-infected adult female Anopheles mosquitoes. Ivermectin, an anti-parasitic drug, acts by killing mosquitoes that are exposed to the drug while feeding on the blood of people (known as blood feeds) who h
- Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection
Cochrane Systematic Reviews, 18-Jan-2016
Strongyloidiasis is a gut infection with Strongyloides stercoralis which is common world wide. Chronic infection usually causes a skin rash, vomiting, diarrhoea or constipation, and respiratory problems, and it can be fatal in people with immune deficienc
- Janus kinase inhibitors for the treatment of COVID‐19
Cochrane Systematic Reviews, 13-Jun-2022
With potential antiviral and anti-inflammatory properties, Janus kinase (JAK) inhibitors represent a potential treatment for symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. They may modulate the exuberant immune respons
- Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
Cochrane Systematic Reviews, 10-Apr-2015
Myelofibrosis is a bone marrow disorder characterized by excessive production of reticulin and collagen fiber deposition caused by hematological and non-hematological disorders. The prognosis of myelofibrosis is poor and treatment is mainly palliative. Ja
- Joint lavage for osteoarthritis of the knee
Cochrane Systematic Reviews, 13-Apr-2010
Osteoarthritis is the most common form of joint disorder and a leading cause of pain and physical disability. Observational studies suggested a benefit for joint lavage, but recent, sham-controlled trials yielded conflicting results, suggesting joint lava
- Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
Cochrane Systematic Reviews, 23-Aug-2016
Kangaroo mother care (KMC), originally defined as skin-to-skin contact between a mother and her newborn, frequent and exclusive or nearly exclusive breastfeeding, and early discharge from hospital, has been proposed as an alternative to conventional neona
- Kava extract versus placebo for treating anxiety
Cochrane Systematic Reviews, 20-Jan-2003
Constraints on resources and time often render treatments for anxiety such as psychological interventions impracticable. While synthetic anxiolytic drugs are effective, they are often burdened with adverse events. Other options which are effective and saf
- Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
Cochrane Systematic Reviews, 8-Oct-2021
Glutamergic system dysfunction has been implicated in the pathophysiology of bipolar depression. This is an update of the 2015 Cochrane Review for the use of glutamate receptor modulators for depression in bipolar disorder.
- Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
Cochrane Systematic Reviews, 12-Sep-2021
Many studies have recently been conducted to assess the antidepressant efficacy of glutamate modification in mood disorders. This is an update of a review first published in 2015 focusing on the use of glutamate receptor modulators in unipolar depression.
- Ketamine as an adjuvant to opioids for cancer pain
Cochrane Systematic Reviews, 28-Jun-2017
This is an update of a review first published in 2003 and updated in 2012.
- Ketamine for management of acute exacerbations of asthma in children
Cochrane Systematic Reviews, 14-Nov-2012
Asthma is the most common chronic disease in children, and children with asthma frequently visit the paediatric emergency departments with acute exacerbations. Some of these children fail to respond to standard therapy (aerosol beta2-agonist with or witho
- Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis
Cochrane Systematic Reviews, 27-Apr-1998
Scleroderma is a connective tissue disease causing fibrosis and commonly affects the skin and internal organs such as the GI tract, lungs, kidney and heart. Most people with scleroderma also have Raynaud's phenomenon (RP). One of the possible treatment op
- Ketogenic diets for drug‐resistant epilepsy
Cochrane Systematic Reviews, 24-Jun-2020
Ketogenic diets (KDs) are high in fat and low in carbohydrates and have been suggested to reduce seizure frequency in people with epilepsy. Such diets may be beneficial for children with drug-resistant epilepsy.
- Ketoprofen for episodic tension‐type headache in adults
Cochrane Systematic Reviews, 22-Sep-2016
Tension-type headache (TTH) affects about 1 person in 5 worldwide. It is divided into infrequent episodic TTH (fewer than one headache day per month), frequent episodic TTH (2 to 14 headache days per month), and chronic TTH (15 headache days a month or mo
- Ketorolac for postoperative pain in children
Cochrane Systematic Reviews, 7-Jul-2018
Children who undergo surgical procedures in ambulatory and inpatient settings are at risk of experiencing acute pain. Nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce moderate to severe pain without many of the side effects associated with opioids
- Ketotifen alone or as additional medication for long‐term control of asthma and wheeze in children
Cochrane Systematic Reviews, 26-Jan-2004
Ketotifen is an antihistamine which may be used to treat asthma. Since administering inhaled therapy to younger children can be difficult, an oral agent such as ketotifen offers potential advantages.
- Kinesio taping for rotator cuff disease
Cochrane Systematic Reviews, 8-Aug-2021
Kinesio Taping (KT) is one of the conservative treatments proposed for rotator cuff disease. KT is an elastic, adhesive, latex-free taping made from cotton, without active pharmacological agents. Clinicians have adopted it in the rehabilitation treatment
